Pharma & Biotech

Iovance Biotherapeutics experienced a severe sell-off in the most recent trading session, with its shares plummeting 4.7 percent. The decline...

Inmune Bio's stock extended its decline in Friday's trading session, closing at $2.01 after a drop of 0.99%. The day's...

EssilorLuxottica (ESLX) experienced a significant boost this week, propelled by two major developments: a landmark regulatory approval for a groundbreaking...

The equity of Harvard Bioscience continues to experience a severe and prolonged decline. Despite the company's efforts to forge new...

The downward trajectory for Assembly Biosciences shares intensified during the latest trading session, marking a third consecutive day of declines....

While Ocugen faces immediate pressure from a collapsed acquisition deal, the biotech firm is simultaneously receiving strong endorsements from two...

Investors in Essa have reacted harshly to a severe downgrade in the proposed terms for its business combination with XenoTherapeutics....

Mersana Therapeutics shares continued their upward trajectory, closing Friday's session with a substantial 5.58% gain at $7.57. This advance extends...

Jasper Therapeutics finds itself navigating turbulent waters as the biotechnology firm contends with a complex mix of regulatory developments, financial...

Shares of Aldeyra Therapeutics experienced a significant rally, climbing 2.92% to reach a price of $5.26. This upward movement is...